OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting
Victoria Chatzimavridou-Grigoriadou, Sami Al-Othman, Georg Brabant, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 11, pp. e4766-e4775
Open Access | Times Cited: 9
Victoria Chatzimavridou-Grigoriadou, Sami Al-Othman, Georg Brabant, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 11, pp. e4766-e4775
Open Access | Times Cited: 9
Showing 9 citing articles:
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management
Annabelle M. Warren, Mathis Grossmann, Mirjam Christ‐Crain, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 5, pp. 819-861
Open Access | Times Cited: 48
Annabelle M. Warren, Mathis Grossmann, Mirjam Christ‐Crain, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 5, pp. 819-861
Open Access | Times Cited: 48
Konsensusempfehlungen zur Diagnose und Therapie der Hyponatriämie der Österreichischen Gesellschaft für Nephrologie 2024
Christoph Schwarz, Gregor Lindner, Martin Windpessl, et al.
Wiener klinische Wochenschrift (2024) Vol. 136, Iss. S1, pp. 1-33
Open Access | Times Cited: 4
Christoph Schwarz, Gregor Lindner, Martin Windpessl, et al.
Wiener klinische Wochenschrift (2024) Vol. 136, Iss. S1, pp. 1-33
Open Access | Times Cited: 4
Low-dose tolvaptan for the treatment of SIADH-associated hyponatremia: a systematic review, meta-analysis, and meta-regression analysis of clinical effectiveness and safety
David Lewellyn, Thitikorn Nuamek, Eduard Oštarijaš, et al.
Endocrine Practice (2025)
Open Access
David Lewellyn, Thitikorn Nuamek, Eduard Oštarijaš, et al.
Endocrine Practice (2025)
Open Access
Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)
Ploutarchos Tzoulis, Gregory Kaltsas, Stephanie Baldeweg, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 7
Ploutarchos Tzoulis, Gregory Kaltsas, Stephanie Baldeweg, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 7
Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD
Anna Arecco, Davide Demontis, Leonardo Della Sala, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Anna Arecco, Davide Demontis, Leonardo Della Sala, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Long-term low-dose tolvaptan efficacy and safety in SIADH
Marta Bondanelli, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine (2023) Vol. 82, Iss. 2, pp. 390-398
Open Access | Times Cited: 6
Marta Bondanelli, Ludovica Aliberti, Irene Gagliardi, et al.
Endocrine (2023) Vol. 82, Iss. 2, pp. 390-398
Open Access | Times Cited: 6
The management of acute and chronic hyponatraemia
Sarah Jean Lawless, Chris Thompson, Aoife Garrahy
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 10
Sarah Jean Lawless, Chris Thompson, Aoife Garrahy
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 10
Efficacy and safety of low-dose tolvaptan (7.5mg) in the treatment of inpatient hyponatraemia: a retrospective study
David C Llewellyn, Eduard Oštarijaš, S. Sahadevan, et al.
Endocrine Practice (2024)
Open Access | Times Cited: 1
David C Llewellyn, Eduard Oštarijaš, S. Sahadevan, et al.
Endocrine Practice (2024)
Open Access | Times Cited: 1
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
Annabelle M. Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Annabelle M. Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 4
